
Boston Scientific (NYSE:BSX) Releases Q1 2026 Earnings Guidance
Boston Scientific (NYSE:BSX – Get Free Report) updated its first quarter 2026 earnings guidance on Wednesday. The company provided EPS guidance of 0.780-0.800 for the period, compared to the consensus EPS estimate of 0.790. The company issued revenue guidance of $5.1 billion-$5.2 billion, compared to the consensus revenue estimate of $5.2 billion. Boston Scientific also [...]










